ロード中...
Suppressors of cytokine signaling: Potential immune checkpoint molecules for cancer immunotherapy
Inhibition of immune checkpoint molecules, PD‐1 and CTLA4, has been shown to be a promising cancer treatment. PD‐1 and CTLA4 inhibit TCR and co‐stimulatory signals. The third T cell activation signal represents the signals from the cytokine receptors. The cytokine interferon‐γ (IFNγ) plays an import...
保存先:
| 出版年: | Cancer Sci |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5406529/ https://ncbi.nlm.nih.gov/pubmed/28188673 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.13194 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|